Logo

American Heart Association

  2
  0


Final ID: 4163750

Cryoballoon Ablation versus Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation (CRRF-PeAF): A Prospective, Multicenter, Randomized, Non-inferiority Clinical Trial

Abstract Body (Do not enter title and authors here): Hypothesis and Purpose:
The primary hypothesis of the CRRF-PeAF study was that cryoballoon (CB) ablation is not inferior to radiofrequency (RF) ablation with respect to the clinical efficacy in patients with persistent atrial fibrillation (PeAF). The purpose of this study was to compare the efficacy and safety of catheter ablation (CA) between CB and RF ablation in patients with PeAF.
Methods:
Study Design
The CRRF-PeAF study is a prospective, multicenter, open-label, controlled, randomized, non-inferiority clinical trial comparing the efficacy and safety of AF ablation at 1-year with a blanking period (BP) of 90 days between CB and RF ablation in patients with PeAF.
Population Studied
Patients aged 20 - 85 years with PeAF were eligible for the study. We randomized 500 individuals across 11 centers in Japan between April 2021 and June 2023, allocating them in a 1-to-1 fashion to undergo either CB or RF ablation.
Interventions
Pulmonary vein isolation (PVI) was mandatory for all patients undergoing CA of AF. Adjunctive ablation lesion sets targeting sites outside the PVs were performed at the physician’s direction.
Follow-up
One-channel electrocardiograms were recorded twice daily for 1-year after CA, using an ambulatory electrogram recorder, in addition to other scheduled examinations, including 12-lead ECGs and 24-hour Holter recordings at 3- and 12-months after CA. All documented atrial tachyarrhythmias (ATs) lasting ≥ 30 seconds occurring outside the 90-day BP were considered recurrences.
The primary and Secondary End Points
The primary endpoint was the occurrence of ATs at 1-year with a 90-day BP after CA. The key secondary endpoints were as follows: success rate of PVI, total procedural time, LA (left atrial) dwelling time, complication rate, change in LA volume index, QoL, hospitalization for heart failure, and mortality.
Sample Size and Statistical analysis
A freedom rate at 1-year of 60% in both groups was assumed, and the non-inferiority hypothesis was evaluated using a log-rank test with a non-inferiority margin for a hazard ratio of 1.5. The sample size was calculated as 239 patients per group with a power of 80% based on a significance level of 2.5%. To account for potential loss to follow-up, 500 patients (250 patients per group) were enrolled.
Results:
The results of this study are currently under investigation.
Conclusion:
The CRRF-PeAF study is underway to compare the efficacy and safety of CA of AF between CB and RF ablation in patients with PeAF.
  • Miyamoto, Koji  ( National Cerebral and Cardiovascular Center , Toyonaka , Japan )
  • Fukaya, Hidehira  ( Kitasato University School of Medicine , Sagamihara , Japan )
  • Ashikaga, Keiichi  ( Miyazaki Medical Association Hospital , Miyazaki , Japan )
  • Kobori, Atsushi  ( Kobe City Medical Center General Hospital , Kobe , Japan )
  • Iwasaki, Yuki  ( Nippon Medical School , Tokyo , Japan )
  • Murakami, Masato  ( Shonan Kamakura General Hospital , Kamakura , Japan )
  • Satomi, Kazuhiro  ( , Tokyo , Japan )
  • Yamauchi, Yasuteru  ( Japan Red Cross Yokohama City Bay Hospital , Yokohama , Japan )
  • Nitta, Junichi  ( Sakakibara Heart Institute , Fuchu, Tokyo , Japan )
  • Takagi, Masahiko  ( Kansai Medical University , Moriguchi , Japan )
  • Kusano, Kengo  ( National Cerebral and Cardiovascular Center , Toyonaka , Japan )
  • Kanaoka, Koshiro  ( National Cerebral and Cardiovascular Center , Toyonaka , Japan )
  • Kishihara, Jun  ( Kitasato University School of Medicine , Sagamihara , Japan )
  • Sasaki, Yasuhiro  ( Kobe City Medical Center General Hospital , Kobe , Japan )
  • Mizuno, Shingo  ( Shonan Kamakura General Hospital , Kamakura , Japan )
  • Yamagami, Shintaro  ( Tenri Hospital , Tenri , Japan )
  • Yazaki, Yoshinao  ( Tokyo Medical University Hospital , Tokyo , Japan )
  • Nishiuchi, Suguru  ( Gunma Prefectural Cardiovascular Center , Maebashi , Japan )
  • Kataoka, Naoya  ( University of Toyama , Toyama , Japan )
  • Author Disclosures:
    Koji Miyamoto: DO have relevant financial relationships ; Researcher:Medtronic:Active (exists now) ; Speaker:Abbott:Active (exists now) ; Speaker:Biosense Webster:Active (exists now) ; Speaker:Medtronic:Active (exists now) | Hidehira Fukaya: DO have relevant financial relationships ; Speaker:Medtronic:Active (exists now) | Keiichi Ashikaga: No Answer | Atsushi Kobori: DO NOT have relevant financial relationships | Yuki Iwasaki: No Answer | Masato Murakami: DO have relevant financial relationships ; Speaker:Medtronic:Past (completed) ; Speaker:Boston:Past (completed) | Kazuhiro Satomi: DO NOT have relevant financial relationships | yasuteru yamauchi: DO NOT have relevant financial relationships | Junichi Nitta: No Answer | Masahiko Takagi: DO NOT have relevant financial relationships | Kengo Kusano: DO NOT have relevant financial relationships | Koshiro Kanaoka: DO NOT have relevant financial relationships | Jun Kishihara: No Answer | Yasuhiro Sasaki: No Answer | Shingo Mizuno: No Answer | SHINTARO YAMAGAMI: No Answer | Yoshinao Yazaki: No Answer | Suguru Nishiuchi: DO NOT have relevant financial relationships | Naoya Kataoka: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Revolutionizing AF Management: Cutting-Edge Approaches

Monday, 11/18/2024 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
A randomized controlled trial of antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherosclerosis: The ATIS-NVAF trial

Okazaki Shuhei, Uchida Kazutaka, Asakura Koko, Omae Katsuhiro, Yamamoto Haruko, Hirano Teruyuki, Toyoda Kazunori, Iguchi Yasuyuki, Noguchi Teruo, Okada Yasushi, Kitagawa Kazuo, Tanaka Kanta, Sakai Nobuyuki, Yamagami Hiroshi, Yazawa Yukako, Doijiri Ryosuke, Koga Masatoshi, Ihara Masafumi, Yamamoto Shiro, Kamiyama Kenji, Honda Yuko

1-Year Outcomes After Cardioversion With and Without Anticoagulation in Patients With Left Atrial Appendage Occlusion: A Propensity-Matched Analysis

Thangjui Sittinun, Trongtorsak Angkawipa, Kewcharoen Jakrin, Thyagaturu Harshith, Watson Hangyu, Mensah Samuel, Balla Sudarshan, Navaravong Leenhapong

More abstracts from these authors:
Endothelium dependent and non-dependent effects of age and blood pressure on the progression of arterial stiffness in hypertension

Nakano Hiroki, Tomiyama Hirofumi, Shiina Kazuki, Kani Junya, Fujii Masatsune, Matsumoto Chisa, Yamashina Akira, Satomi Kazuhiro

Clinical Utility of T2 Mapping for the Assessment of Myocardial Inflammation in Patients With Cardiac Sarcoidosis

Uno Mio, Kosuge Hisanori, Fujita Yasuhiro, Hida Satoshi, Satomi Kazuhiro

You have to be authorized to contact abstract author. Please, Login
Not Available